{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:12:45Z","timestamp":1755216765204,"version":"3.43.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:p>Plasmablastic lymphoma (PBL) occurs in the setting of immunodeficiency, in association with human immunodeficiency virus (HIV) infection, in elderly patients, and in the posttransplantation state. It is exceptionally rare in children. PBL is an aggressive lymphoma with a poor prognosis. We present a case of pediatric PBL in an HIV-positive child with suspicion of a concomitant underlying immune deficiency state other than HIV. A 7-year-old girl presented to the pediatric emergency department with complaints of fever and painful swelling on the left side of her face for 15 days, associated with headache, snoring, and difficulty in breathing. She had a history of watery diarrhea, oral thrush, recurrent fever, and hospitalizations for skin infections since the age of 1 year. Histopathological findings were consistent with PBL. Her HIV RNA polymerase chain reaction was positive. She was offered chemotherapy based on the FAB\/LMB 96 protocol. This case demonstrates an aggressive presentation of a rare entity, HIV-associated PBL, in a child, with underlying immunodeficiency and highlights the issues which caused a significant challenge in making the diagnosis. The presence of HIV infection and contradicting other immunologic investigations posed a dilemma in establishing an association of PBL in this child. The outcome of patients with this tumor is associated with high mortality.<\/jats:p>","DOI":"10.1097\/mph.0000000000002733","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T09:05:27Z","timestamp":1690880727000},"page":"e931-e935","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Plasmablastic Lymphoma in a Human Immunodeficiency Virus-positive Child With a Suspicion of Concomitant Primary Immunodeficiency Disorder"],"prefix":"10.1097","volume":"45","author":[{"given":"Nausheen","family":"Yaqoob","sequence":"first","affiliation":[{"name":"Department of Histopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabiha","family":"Anis","sequence":"additional","affiliation":[{"name":"Department of Immunology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelum","family":"Mansoor","sequence":"additional","affiliation":[{"name":"Department of Hematology and Blood Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naema","family":"Khayyam","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Indus Hospital and Health Network, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saba","family":"Jamal","sequence":"additional","affiliation":[{"name":"Department of Histopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/jop.13210","article-title":"Oral plasmablastic lymphoma: a clinicopathological study of 113 cases","volume":"50","author":"Fonseca","year":"2021","journal-title":"J Oral Pathol Med"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"e2014064","DOI":"10.4084\/mjhid.2014.064","article-title":"Current knowledge on HIV-associated plasmablastic lymphoma","volume":"6","author":"Bibas","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/his.13964","article-title":"Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area","volume":"76","author":"Meer","year":"2020","journal-title":"Histopathol"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5045\/br.2020.55.1.49","article-title":"HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases","volume":"55","author":"Li","year":"2020","journal-title":"Blood Res"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/0002-9343(78)90537-5","article-title":"Case report malignant lymphoma of plasmablastic identity: a neoplasm with both \u201cimmunoblastic\u201d and plasma cellular features","volume":"64","author":"Banks","year":"1978","journal-title":"Am J Med"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-015-0163-z","article-title":"Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients","volume":"8","author":"Loghavi","year":"2015","journal-title":"J Hematol Oncol"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/jclinpath-2016-204294","article-title":"Plasmablastic lymphoma versus plasmablastic myeloma: an ongoing diagnostic dilemma","volume":"70","author":"Ahn","year":"2017","journal-title":"J Clin Pathol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/his.13959","article-title":"High incidence of MYC rearrangement in human immunodeficiency virus-positive plasmablastic lymphoma","volume":"76","author":"Miao","year":"2020","journal-title":"Histopathol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/modpathol.2016.162","article-title":"Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1","volume":"30","author":"Montes-Moreno","year":"2017","journal-title":"Mod Pathol"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3324\/haematol.2020.251579","article-title":"Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma","volume":"106","author":"Garcia-Reyero","year":"2021","journal-title":"Haematologica"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ajcp\/aqw200","article-title":"Immunodeficiency and dysregulation: report of the 2015 Workshop of the Society for Hematopathology\/European Association for Haematopathology","volume":"147","author":"Natkunam","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"R17-20250804","first-page":"63","article-title":"Plasmablastic lymphoma: current perspectives","volume":"4","author":"Lopez","year":"2018","journal-title":"Blood Lymphat Cancer"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fimmu.2018.00113","article-title":"First occurrence of plasmablastic lymphoma in adenosine deaminase-deficient severe combined immunodeficiency disease patient and review of the literature","volume":"9","author":"Migliavacca","year":"2018","journal-title":"Front Immunol"},{"key":"R19-20250804","first-page":"11","article-title":"Relationship of serum immunoglobulin and IgG subclass levels to race, ethnicity and behavioral characteristics in HIV infection","volume":"12","author":"McGowan","year":"2006","journal-title":"Med Sci Monit"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/cid\/cit232","article-title":"CD4 decline is associated with increased risk of cardiovascular disease, cancer, and death in virally suppressed patients with HIV","volume":"57","author":"Helleberg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar4032","article-title":"Common variable immunodeficiency-an update","volume":"14","author":"Salzer","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2500\/ajra.2013.27.3899","article-title":"Common variable immunodeficiency","volume":"27","author":"Tam","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-022-02683-9","article-title":"Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China","volume":"20","author":"Shi","year":"2022","journal-title":"BMC Med"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1365-2559.2001.01039.x","article-title":"Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteria","volume":"38","author":"Canioni","year":"2001","journal-title":"Histopathol"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s12185-021-03211-w","article-title":"Heterogeneity in the diagnosis of plasmablastic lymphoma, plasmablastic myeloma, and plasmablastic neoplasm: a scoping review","volume":"114","author":"Mori","year":"2021","journal-title":"Int J Hematol"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"E389","DOI":"10.1002\/dc.24829","article-title":"An unusual case of paediatric plasmablastic lymphoma presenting with malignant effusion and the challenges in its diagnosis","volume":"49","author":"Modi","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1002\/cncr.27551","article-title":"Human immunodeficiency virus\u2010associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy","volume":"118","author":"Castillo","year":"2012","journal-title":"Cancer"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41408-020-0327-0","article-title":"Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients","volume":"10","author":"Witte","year":"2020","journal-title":"Blood Cancer J"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/annonc\/mdw684","article-title":"Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group","volume":"28","author":"Tchernonog","year":"2017","journal-title":"Ann Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:07:24Z","timestamp":1754338044000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002733","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2023,7,26]]},"assertion":[{"value":"2022-11-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}